Stock listing

48Q0 Stock Price, News, Filings & Events — X4 Pharmaceuticals, Inc.

Selected listing: 48Q0 · GETTEX · EUR · DE

This page tracks X4 Pharmaceuticals, Inc.'s 48Q0:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 48Q0:GETTEX. 48Q0:GETTEX is the stock-level entry point for investors researching X4 Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. X4 Pharmaceuticals, Inc. (ticker: XFOR) is a public company based in the United States, focusing on developing innovative therapies for rare diseases. With a market capitalization of approximately $360.3 million, X4 is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company operates within the pharmaceutical sector, emphasizing research and development in its strategic initiatives.

48Q0:GETTEXEURDEUpdated September 4, 2026
X4 Pharmaceuticals, Inc. logo
Ticker
48Q0:GETTEX
Asset type
Stock
Market cap
$400.6M
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

X4 Pharmaceuticals, Inc. 48Q0:GETTEX stock context

This page tracks X4 Pharmaceuticals, Inc.'s 48Q0:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 48Q0:GETTEX. 48Q0:GETTEX is the stock-level entry point for investors researching X4 Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. X4 Pharmaceuticals, Inc. (ticker: XFOR) is a public company based in the United States, focusing on developing innovative therapies for rare diseases. With a market capitalization of approximately $360.3 million, X4 is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company operates within the pharmaceutical sector, emphasizing research and development in its strategic initiatives.

Latest news from X4 Pharmaceuticals, Inc.

All X4 Pharmaceuticals, Inc. news →

X4 Pharmaceuticals, Inc. earnings calls

Research X4 Pharmaceuticals, Inc.

Alternate listings